Press enter or spacebar to select a desired language.
Press enter or spacebar to select a desired language.
Guidelines International Network (GIN)
Powered by EBSCO

Guidelines International Network

3371 - 3380 of 3694 results found

Treatment of Anemia in Patients with Heart Disease: A Clinical Practice Guideline From the American College of Physicians

MeSH Terms
Hematinics (D27.505.954.502.543); Injections; Intravenous (E02.319.267.082.750); Iron (D01.552.544.412); Iron (D01.268.956.287); Iron (D01.268.556.412); Anemia; Iron-Deficiency (C15.378.071.196.300); Anemia; Iron-Deficiency (C18.452.565.100); Coronary Disease (C14.907.585.250); Coronary Disease (C14.280.647.250); Erythrocyte Transfusion (E02.095.135.140.275); Exercise Tolerance (G11.427.680.270); Heart Failure (C14.280.434)
Guideline Contact
Amir Qaseem ([email protected])
Publication Scope
management
Countries of Application
United States
Guideline Publication Status
Published
Languages
English
Authors
ACP (US)
Publication Year
2013

Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline

MeSH Terms

Adult

Bone Density Conservation Agents* / therapeutic use

Diphosphonates / therapeutic use

Humans

Hypercalcemia* / drug therapy

Hypercalcemia* / etiology

Neoplasms* / complications

Paraneoplastic Syndromes

Guideline Contact
Maureen Corrigan ([email protected])
Publication Scope
Evidence-Based Medicine
Countries of Application
International
Guideline Publication Status
Published
Languages
English
Authors
Endocrine Society
Willingness to Collaborate
Yes
Publication Year
2022

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians

MeSH Terms
Vitamin D (D04.808.812.768); Women (M01.975); Osteoporosis (C05.116.198.579); Pharmacologic Actions (D27.505); Therapeutic Uses (D27.505.954); Alendronate (D02.705.429.500.100); Peptide Hormones (D06.472.699); Peptide Hormones (D12.644.548); Teriparatide (D06.472.699.590.850); Teriparatide (D12.644.548.587.850); Calcitonin (D06.472.699.150); Calcitonin (D12.644.400.095); Calcitonin (D12.644.548.150); Calcitonin (D12.776.641.650.095); Estrogen Replacement Therapy (E02.319.452.150); Selective Estrogen Receptor Modulators (D27.505.696.399.450.360.827); Selective Estrogen Receptor Modulators (D06.347.360.827); Raloxifene (D02.455.426.559.389.150.700.900.775); Osteoporosis; Postmenopausal (C05.116.198.579.610); Calcium (D01.268.552.100); Calcium (D01.552.539.288)
Guideline Contact
Amir Qaseem ([email protected])
Date for Review
2006-06-22
Publication Scope
prevention
treatment
Countries of Application
United States
Guideline Publication Status
Published
Languages
English
Authors
ACP (US)
Publication Year
2017

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

MeSH Terms
Multiple Myeloma (C04.557.595.500); Stem Cell Transplantation (E04.936.225.687); Maintenance Chemotherapy (E02.319.509)
Guideline Contact
[email protected]
Expected Publication Date
01-Apr-19
Publication Scope
management
treatment
Countries of Application
Canada
United States
Guideline Publication Status
Published
Languages
English
Authors
ASCO (US)
Publication Year
2019

Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline

MeSH Terms
Urinary Bladder Neoplasms (C04.588.945.947.960)
Guideline Contact
[email protected]
Publication Date
10-Aug-17
Publication Scope
management
Countries of Application
United States
Guideline Publication Status
Published
Languages
English
Authors
ASCO (US)
ASTRO (US)
Publication Year
2017
My Saved Lists